Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potentially serious side-effects of high-dose twice-weekly rifampicin.

× No keyword cloud information.

14 in total

1. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].

Authors: D Larbaoui; P Chaulet; J Grosset; K Abderrahim; N Oussedik; C Coucke; L Benabdallah
Journal: Rev Tuberc Pneumol (Paris) Date: 1970-06

2. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.

Authors: A Gyselen; L Verbist; J Cosemans; L M Lacquet; J Prignot; F Simon-Pouthier; R Debrabandere; J Devriendt
Journal: Acta Tuberc Pneumol Belg Date: 1969

3. Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.

Authors: L Verbist; A Gyselen
Journal: Am Rev Respir Dis Date: 1968-12

4. A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.

Authors: C V Ramakrishnan; S Devadatta; C Evans; W Fox; N K Menon; O Nazareth; S Radhakrishna; S Sambamoorthy; H Stott; S P Tripathy; S Velu
Journal: Tubercle Date: 1969-06

5. [Jaundice during treatment with rifampicin (12 cases)].

Authors: R Lesobre; J Ruffino; L Teyssier; F Achard; G Brefort
Journal: Rev Tuberc Pneumol (Paris) Date: 1969 Apr-May

6. Coombs'-test positivity induced by drugs. Mechanisms of immunologic reactions and red cell destruction.

Authors: J D Croft; S N Swisher; B C Gilliland; R F Bakemeier; J P Leddy; R I Weed
Journal: Ann Intern Med Date: 1968-01 Impact factor: 25.391

7. Trial of sanatorium treatment including a comparison of standard and intermittent continuation chemotherapy: Central Bohemian Tuberculosis Services-WHO-British Medical Research Council investigation.

Authors: F Polansky
Journal: Bull Int Union Tuberc Date: 1970-06

8. Jaundice after rifampicin.

Authors: A W Lees; B Asgher; M A Hashem; B N Sinha
Journal: Br J Dis Chest Date: 1970-04

9. Twice-weekly streptomycin plus isoniazid for tuberculosis.

Authors: P Stradling; G W Poole
Journal: Tubercle Date: 1970-03

10. Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.

Authors: F Grumbach; G Canetti; M Le Lirzin
Journal: Tubercle Date: 1969-09

4 in total

1. Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Authors: Timothy R Sterling; Ruth N Moro; Andrey S Borisov; Elizabeth Phillips; Gillian Shepherd; Newton Franklin Adkinson; Stephen Weis; Christine Ho; Margarita Elsa Villarino
Journal: Clin Infect Dis Date: 2015-04-22 Impact factor: 9.079

2. Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.

Authors: Meredith Milstein; Leonid Lecca; Charles Peloquin; Denis Mitchison; Kwonjune Seung; Marcello Pagano; David Coleman; Elna Osso; Julia Coit; Dante Elmo Vargas Vasquez; Epifanio Sanchez Garavito; Roger Calderon; Carmen Contreras; Geraint Davies; Carole D Mitnick
Journal: BMC Infect Dis Date: 2016-08-27 Impact factor: 3.090

3. Early Detection of Acute Drug-Induced Liver Injury in Mice by Noninvasive Near-Infrared Fluorescence Imaging.

Authors: Kristine O Vasquez; Jeffrey D Peterson
Journal: J Pharmacol Exp Ther Date: 2017-01-23 Impact factor: 4.030

Review 4. Acute kidney injury induced by antimicrobial agents in the elderly: awareness and mitigation strategies.

Authors: Fumihiro Mizokami; Tomohiro Mizuno
Journal: Drugs Aging Date: 2015-01 Impact factor: 4.271

4 in total